This document provides information about acute myeloid leukemia (AML), including its definition, classification, predisposing factors, pathogenesis, clinical features, morphology, investigations, and prognosis. AML is a malignant clonal disorder originating from hematopoietic stem cells characterized by proliferation of immature blast cells in the bone marrow with a rapidly fatal course without treatment. It is classified based on morphological and cytogenetic features, with common genetic abnormalities involving transcription factors required for normal myeloid differentiation. Prognosis depends on specific cytogenetic abnormalities, with translocations like t(8;21) and inv(16) conferring a better prognosis.